Product Information
XIGDUO XR 5 MG-1,000 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $9.5904 per EA under NDC 00310626060. Its NADAC has been published 601 times since Feb 18, 2015.
FDA first approved this application on Oct 29, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 1000 mg/1; mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310626060
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205649FDA Approved
10/29/2014
TE Code
AB
On Market Since
10/29/2014
Pharmacological Classes
Price Statistics
The NADAC for XIGDUO XR 5 MG-1,000 MG TABLET has been published 601 times since Feb 18, 2015, and over the history we have for it it has risen 91.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.5904 per EA |
|---|---|
| All-time high | $9.6014 (Mar 11, 2026) |
| All-time low | $5.0149 (Feb 18, 2015) |
| 52-week high | $9.6014 |
| 52-week low | $9.5842 |
| Median price | $8.2617 |
| Average price | $8.0625 |
| Largest weekly change | +9.9% (Feb 25, 2015) |
| Weeks tracked | 601 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of XIGDUO XR 5 MG-1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for XIGDUO XR 5 MG-1,000 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $9.5904 per EA (NDC 00310626060), effective Aug 19, 2026.
How has the price of XIGDUO XR 5 MG-1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for XIGDUO XR 5 MG-1,000 MG TABLET has risen 91.2%. It has been tracked across 601 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for XIGDUO XR 5 MG-1,000 MG TABLET?
Since Feb 18, 2015, the NADAC for XIGDUO XR 5 MG-1,000 MG TABLET has ranged from a low of $5.0149 (Feb 18, 2015) to a high of $9.6014 (Mar 11, 2026), with a median of $8.2617 per EA.
Are there cheaper alternatives to XIGDUO XR 5 MG-1,000 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DAPAGLIFLOZIN-METFORMIN ER 5-1,000 MG TABLET, is $0.4755 per EA — about 95% below XIGDUO XR 5 MG-1,000 MG TABLET.
Who manufactures XIGDUO XR 5 MG-1,000 MG TABLET?
XIGDUO XR 5 MG-1,000 MG TABLET (NDC 00310626060) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.